Pharma spending $1.2M a day on lobbying; Primary care shortages still threaten reform efforts;

> I've seen some big lobbying pushes, but this is still impressive: Apparently, pharmaceutical companies are spending $1.2 million per day on lobbying activities. FiercePharma

> Yet another data point emerges suggesting that primary care shortages could undercut reform efforts. The article, from the Dallas Morning News, notes that the shortage could prevent Congress from providing adequate medical access to many currently uninsured patients. Article

> While the notion isn't new, this time the plug is coming from an economist at Harvard rather than some vendor or think tank. Smart HIT use, he says, could transform the healthcare industry by automating scores of paper processes. FierceHealthIT

> A successful consultant, speaker and general surgeon--with an MBA, yet--describes how he's weathering the down economic climate without getting bitter or burned out. Hospital Impact

And Finally... Sure, I got my wallet back after losing it 27 years ago, but hey, what happened to my $20 bucks? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.